Hydrocolloid Dressing Market Size, Share & Trends Analysis Report By Application (Acute Wounds, Chronic Wounds), By End-use (Hospitals, Specialty Clinics), By Region (EU, Asia Pacific, North America), And Segment Forecasts, 2022 - 2030

Report Overview

The global hydrocolloid dressing market size was valued at USD 1.31 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 4.99% from 2022 to 2030. The market is primarily driven by the rising prevalence of chronic and acute wounds. For instance, according to recent estimates published in NCBI (2017), chronic wounds impact around 5.7 million people in the U.S. Similarly, the Independent Diabetes Trust in the U.K. claimed in its report (2019) that each year, around 115,000 people get diabetic foot ulcers, while 278,000 people are treated for venous leg ulcers. Moreover, the increased prevalence of severe burn injuries will boost the market growth. According to ebmedicine.net, about 265,000 individuals worldwide die as a result of thermal burns.

Similarly, the NCBI estimates that 450,000 people undergo burn treatment each year. Thermal burns account for 86% of all burns, whereas chemical burns account for 3%, electric burns account for 4%, and miscellaneous burns account for 7%. Furthermore, the growing incidence ofroad accidents, burns, and trauma events is projected to drive thegrowth. For instance, according to the WHO (2018), in India, about 1,000,000 severe or moderate burn cases are reported annually. Moreover, according to the U.S. fire administration, in 2019, 1,291,500 fire incidents were registered, wherein 16,600 people were injured and 3,704 people died.

In addition, as per the WHO data, approximately 1.3 million people die each year as a result of road traffic crashes. Similarly, according to the Brake organization, worldwide, between 20 and 50 million non-fatal injuries resulting from traffic accidents each year. Such accidents frequently result in significant blood loss and other injuries, necessitating prompt medical treatment and surgical procedures to offer patients instant relief. Thus, the rising prevalence of chronic and acute wounds is likely to boost the demand for hydrocolloid dressings, as they are effective for acute and chronic wounds of varying thicknesses.

They encourage autolytic debridement of sloughy or necrotic tissue. They stick effectively to high-friction areas like the heels and the sacrum and are used to treat pressure injuries. Hydrocolloid dressings are also utilized as protective dressings in the ICU for intubated patients to minimize device-related pressure injuries. They are also used to treat minor burns and abrasions. Thereby, the aforementioned factors are driving the hydrocolloid dressing market growth. Hydrocolloid technology has been employed in advanced wound care for many years due to its absorbency and capacity to establish a protective barrier over the skin.

Recent hydrocolloid advancements, particularly the use of additives, have significantly enhanced patient care. Manufacturers of hydrocolloid PSA are now able to produce dressings with extended wear periods owing to next-generation extrusion technology. Modern hydrocolloid extruders produce materials more effectively, more consistently, and with less waste. Another breakthrough in the hydrocolloid family is the development of hybrid materials that combine hydrocolloid and acrylic PSA. One such advancement is Avery Dennison Medical’s proprietary Thin Absorbent Skin Adhesive (TASA).

This adhesive can be applied to a variety of carrier materials, such as polyurethane films and nonwovens. TASA is 0.1 mm thick, whereas standard hydrocolloid adhesives are generally 0.3-1.0 mm thick. It also promotes breathability and absorbency. These superior fluid-handling capabilities allow for wear durations of up to seven days. Thereby, such advances and developments have opened many new possibilities for an enhanced patient experience, driving themarket. Furthermore, there are several advantages of using a hydrocolloid dressing for advanced wound care, including high durability, faster healing, reduced pain, lower risk of infection, and adherence only to surrounding skin.

Moreover, hydrocolloids are easyto use, cost-effective, flexible, and waterproof.They can create an excellent protective barrier for newly healed skin that is still intact or for partially healed wounds that might need protection from possible surface damage. Thereby, owing to the aforementioned benefits provided by hydrocolloid dressings, their adoption is likely to surge in the forecast period. The COVID-19 pandemic had a detrimental impact on the market, due to the cancellation or postponement of elective procedures. However, increased telehealth and virtual consultation penetration have aided the market’s recovery post-pandemic. For instance:

• In January 2021, Delta Care Rx introduced a virtual wound care consultation service that brings an expert wound care physician and nurse to collaborate with hospice and palliative care nurses

• In February 2021, the Digital Technology Supercluster invested USD 2.5 million into a new USD 3.1 million initiative - Telewound Care Canada, intended to aid wound patients access care virtually

• Wound Pros offers a telemedicine platform that allows wound care teams and patients to safely connect. It also just debuted “RITA”, a revolutionary diagnostic and wound evaluation app

• According to a research article published in Medline Industries LP, independent medical practices offering telemedicine surged from 22% pre-pandemic to 41% post-pandemic. Similarly, post-pandemic, 60% of consumers are willing to use telehealth as compared to 49% before the pandemic

Furthermore, multiple research studies indicate that telemedicine alternatives are a cost-effective strategy to enhance wound care results while increasing patient compliance and satisfaction. Furthermore, insurance coverage has started to cover telemedicine. As a result of the aforementioned cases, the market is expected to develop at a rapid pace in the post-pandemic period.

Application Insights

The acute wounds segment is expected to grow at the fastest CAGR of 5.11% during the forecast period. The surgical & traumatic wounds segment held the largest share in 2021. The rising number of SSIs is one of the major driving factors for segment growth. Surgical wounds majorly occur due to SSIs. As per a study conducted by Wounds International, the incidence rate of SSI in general surgery was found to be 11.7%, which led to the re-admission of 19.2% of patients during the study period. Furthermore, the rising incidence of trauma is contributing to the segment growth. For instance, as per a study by ResearchGatein 2020, around 6.6% of mortality occursdue to trauma every year.

Moreover, the burns segment is anticipated to witness the fastest growth rate over the forecast period owing to the rising incidence of burn injuries. Around 50.0% of people worldwide are exposed to fire-related traumas and among them, 90.0% of the cases occur in low- to moderate-income countries. As per the Joye Law Firm, on average, there are 450,000 burn injuries throughout the U.S. annually that require medical treatment, and about 3,500 people are fatally injured in a fire or burn accident. Thereby, the rising prevalence of traumatic wounds, SSI and burn injuries are among the key factors anticipated to propel segment growth over the forecast period.

The chronic wounds segment held the largest revenue share in 2021 and is anticipated to witness a considerable growth rate over the forecast period. The increasing incidence of diabetes and diabetic foot ulcers is a major factor driving the segment growth. For instance, according to ScienceDirect, diabetic foot ulcers may affect more than 25% of the diabetic population and may lead to amputation of the foot in 20% of patients. Moreover, according to the American Diabetes Association, in 2018, an estimated 34.2 million people, i.e., 10.5% of the total U.S. population, had diabetes.

Nearly 1.6 million U.S. residents had type 1 diabetes, which includes about 187,000 adolescents and children. According to a similar source, approximately 1.5 million people in the U.S. are diagnosed with diabetes each year. The use of hydrocolloid wound dressings helps such ulcers to heal as they provide a moist wound environment that supports healing and autolytic debridement. Thus, with an increase in the number of patients suffering from diabetesand a rise in the prevalence of diabetic foot ulcers, the segment is expected to grow during the forecast period.

End-use Insights

The hospitals segment held the largest share of more than45.00% of the global revenue in 2021due to a growing patient flow in hospitals suffering from chronic and acute wounds. For instance, as per a research article published by Smith & Nephew, in a typical hospital setting, between 25% and 40% of beds are occupied by patients with wounds. Moreover, the increasing number of surgical procedures is further driving the segment growth. For instance, as per the latest statistics published by a research article in NCB, around 310 million key surgeries are performed annually across the globe, with about 40 to 50 million in the U.S. and 20 million in Europe.

Hydrocolloid dressings are commonly used for surgical incisions, thereby its adoption is likely to increase with the rising volume of surgeries. The aforementioned factors are projected to boost the segment growth during the forecast period. The home healthcare segment is anticipated to grow at the fastest CAGR during the forecast period due to patients’ increasing preference for home care settings for personalized wound care. Most of the surgeries require a prolonged recovery period, leading to frequent changing of dressings. Moreover, the geriatric population suffering from wounds prefer home care over hospital stay.

Conditions, such as diabetic foot ulcers, venous leg ulcers, and surgical wounds, typically necessitate extended hospital stays, which can be difficult for senior patients. Furthermore, due to the rising healthcare expenses, a growing number of individuals with chronic conditions prefer to obtain treatment at home. This trend is expected to boost the demand for hydrocolloid dressings, as they are used to treat, diagnose, and monitor a variety of chronic and acute wounds. Hence, such factors are anticipated to boost the segment growth over the forecast period.

Regional Insights

North America held the largest revenue share of 45.3% in 2021 and is expected to witness a steady CAGR over the forecast period. The region’s dominance is due to the rising prevalence of chronic wounds, higher treatment costs, and availability of appropriate reimbursement programs in the U.S. and Canada. According to an article published in October 2021 by Mary Ann Liebert, Inc., the prevalence of venous leg ulcers among the adult population in the U.S. was roughly 1.69% in 2020. It was also estimated that the yearly economic burden for venous leg ulcers in the U.S. was roughly USD 14.90 billion. Due to the large patient pool suffering from chronic wounds, there is a rising need for and acceptance of advanced wound care products, such as hydrocolloid dressings.

This is responsible for this region’s market domination. Asia Pacific is estimated to witness the highest CAGRover the forecast period. The market is steadily increasing, offering several opportunities for the introduction of new products. Furthermore, medical tourism in this region is increasing, which is increasing the number of surgeries performed. In addition, the increasing focus of major players in the emerging Asian countries and government support are further driving the market in this region. However, the lack of awareness and price sensitivity have significantly hampered the expansion of the advanced wound care management market.

Key Companies & Market Share Insights

The market comprises several large- and small-scale manufacturers. Competitive rivalry and the degree of competition in the market are expected to intensify over the forecast. Frequent merger and acquisition activities are observed in the market, mainly to gain a competitive edge. For instance, in October 2019, 3M expanded its wound care offerings, by completing the acquisition of Acelity, Inc. Thus, with various strategies acquired by leading players, such as collaborations, approvals, product launches, mergers & acquisitions to strengthen their product portfolios, the market is expected to grow during the forecast period. Some prominent players in the global hydrocolloid dressing market include:

• Smith & Nephew

• 3M

• Coloplast Corp

• Convatec Inc.

• Paul Hartmann AG

• B. Braun Melsungen AG

• Cardinal Health

• Covalon Technologies Ltd.

• Dermarite Industries, LLC.

• Medline Industries, Inc.

Hydrocolloid Dressing Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global hydrocolloid dressing market report on the basis of application, end-use, and region:

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Acute Wounds

    • Surgical & Traumatic Wounds

    • Burns

  • Chronic Wounds

    • Diabetic Foot Ulcers

    • Pressure Ulcers

    • Venous Leg Ulcers

    • Other Chronic Wounds

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Specialty Clinics

  • Home Healthcare

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Argentina

    • Mexico

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE